Journal of the American College of Clinical Pharmacy : JACCP最新文献

{"title":"Response to Comment: Utilization of Artificial Intelligence as Simulated Patients to Enhance Student Interviewing Skills in the Pharmacy Curriculum Across Multiple Programs","authors":"Joseph M. Walter, Lucio Volino, Laura Knockel, Erika L. Kleppinger, Jarod Parrish, Rachel Stafford","doi":"10.1002/jac5.70294","DOIUrl":"10.1002/jac5.70294","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148979186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recorded Webcast: Continuous Glucose Monitoring","authors":"Diana Isaacs, Megan Adelman","doi":"10.1002/jac5.70284","DOIUrl":"10.1002/jac5.70284","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148972748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Promoting Clinical Excellence in Community Pharmacy: The Potential and Challenges of Board Certification","authors":"Michelle M. Jeon, Emily Eddy, Kaileigh D. Yen, Rebecca Lahrman","doi":"10.1002/jac5.70297","DOIUrl":"10.1002/jac5.70297","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148979160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recorded Webcast: Insulin Pumps","authors":"Diana Isaacs, Megan Adelman","doi":"10.1002/jac5.70283","DOIUrl":"10.1002/jac5.70283","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148972771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors Associated With Professional Fulfillment, Work Exhaustion, and Job Turnover Intention Among Infectious Diseases Pharmacists","authors":"David A. Mott, Aaron M. Gilson, Samuel L. Aitken, Melissa Johnson, Erin K. McCreary, Elizabeth B. Hirsch","doi":"10.1002/jac5.70288","DOIUrl":"https://doi.org/10.1002/jac5.70288","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Infectious diseases (ID) pharmacists practice in an important therapeutic area and hold critical roles including leading antimicrobial stewardship (AMS) programs and participating in ID clinical services. High United States pharmacist burnout prevalence, before and after the coronavirus disease 2019 (COVID-19) pandemic, ensures pharmacist shortages into the foreseeable future, prioritizing a need to protect ID pharmacist well-being. Accordingly, work exhaustion (exhaustion), low professional fulfillment (fulfillment), and high job turnover intention (turnover) are particularly concerning. This study evaluated associations between work system characteristics and fulfillment, exhaustion, and turnover among ID/AMS pharmacists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The Systems Engineering Initiative for Patient Safety (SEIPS) 2.0 Model was used to guide classification and organization of items from a recent national ID/AMS pharmacist survey to identify work system characteristics associated with exhaustion, fulfillment, and turnover. The sample consisted of 484 licensed US pharmacists reporting involvement in formal or informal ID and/or AMS responsibilities. Multivariate binomial logistic regressions modeled the association of the independent variable domains on each outcome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The proportion of respondents reporting high levels of fulfillment, exhaustion, or turnover was 42%, 24%, and 15%, respectively. High autonomy predicted high fulfillment (odds ratio [OR] = 22.741, <i>p</i> = 0.003) and low turnover (OR = 0.202; <i>p</i> < 0.001). A supervisor who listened to respondent concerns predicted low exhaustion (OR = 0.259, <i>p</i> < 0.001) and high fulfillment (OR = 3.972, <i>p</i> < 0.001). Adequate job resources predicted low exhaustion (OR = 0.200, <i>p</i> < 0.001) and high fulfillment (OR = 3.238, <i>p</i> < 0.001). Additionally, being asked to do activities beyond hiring expectations predicted high exhaustion (OR = 2.340, <i>p</i> = 0.017), while organizational strategies to improve well-being predicted low turnover (OR = 0.315, <i>p</i> = 0.014).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The findings validate the need to examine work system characteristics influencing pharmacists' perceptions about their work life. Strategically, organizations should ensure that ID/AMS programs are resourced appropriately, facilitate pharmacist autonomy, improve pharmacist-leader communication, and manage ID/AMS pharmacists' workload. Improving the","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70288","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148943262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comment on “Utilization of Artificial Intelligence as Simulated Patients to Enhance Student Interviewing Skills in the Pharmacy Curriculum Across Multiple Programs”","authors":"Hillery N. Downey, Marianne Koenig","doi":"10.1002/jac5.70293","DOIUrl":"10.1002/jac5.70293","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148932087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Cross-Sectional Survey of Knowledge, Confidence, and Decision-Making in Acute Stroke in the Era of Anti-Amyloid Therapies","authors":"Preeyaporn Sarangarm,&nbsp;Nicole M. Acquisto,&nbsp;David E. Zimmerman,&nbsp;Adis Keric,&nbsp;Christian Kroll,&nbsp;Brett Faine,&nbsp;Megan A. Rech,&nbsp;EMPHARM-NET","doi":"10.1002/jac5.70291","DOIUrl":"10.1002/jac5.70291","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Anti-amyloid therapies (AATs) for Alzheimer's disease complicate emergency stroke care due to the risk of amyloid-related imaging abnormalities (ARIA), which can mimic acute ischemic stroke (AIS) and increase hemorrhagic risk. We evaluated emergency medicine (EM) providers' (physicians and advanced practice providers) and pharmacists' knowledge, confidence, and clinical decision-making related to AAT-associated ARIA.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A cross-sectional, web-based survey of EM providers and pharmacists practicing in United States hospital-based emergency care settings between February and April 2026 was conducted. Survey domains included familiarity with AATs, confidence in ARIA recognition and management, clinical decision-making, institutional preparedness, and barriers and facilitators to care. Results are reported descriptively, with subgroup comparisons between EM providers and pharmacists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Clinical experience with AAT-related scenarios was limited among the 204 survey participants; 77.5% reported no prior modification of thrombolytic or anticoagulant therapy because of AATs. Self-reported knowledge of AATs was low (mean 2.4 ± 1.3 on a five-point scale), and confidence in recognizing and managing ARIA was limited. EM pharmacists reported greater knowledge and higher confidence in medication-related decision-making than EM providers. Frequent barriers were unfamiliarity with AAT and ARIA, diagnostic overlap with acute ischemic stroke, and limited institutional resources. Most (83.3%) reported a need for additional education.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>EM providers and pharmacists demonstrated substantial gaps in preparedness for patients receiving AATs, including limited knowledge, low confidence, minimal clinical experience, and inadequate institutional support. These findings highlight opportunities for pharmacist-led education, clinical decision support, and multidisciplinary implementation strategies to improve safe management of AAT-associated neurologic emergencies as therapies continue to expand.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148932078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reframing Obesity as a Public Health Problem: How Pharmacists Can Address the Environmental Causes","authors":"Robert J. DiDomenico","doi":"10.1002/jac5.70292","DOIUrl":"10.1002/jac5.70292","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148932015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perceived Value of Board of Pharmacy Specialties Certification Among Hospital Pharmacists in Spain: A Qualitative Interview Study","authors":"Montserrat Viñas-Bastart,&nbsp;Maria-Estela Moreno-Martínez,&nbsp;Sònia Ruiz-Boy,&nbsp;Jan T. De Pourcq,&nbsp;Cristina Martínez Roca,&nbsp;Maria Josep Carreras-Soler,&nbsp;Miguel Ángel Amor García,&nbsp;Beatriz Salazar-Laya,&nbsp;Vicente Faus Felipe,&nbsp;Amaya Rojo García,&nbsp;Javier Letellez Fernández,&nbsp;Pilar Modamio,&nbsp;Josep Maria Guiu-Segura","doi":"10.1002/jac5.70286","DOIUrl":"https://doi.org/10.1002/jac5.70286","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Board of Pharmacy Specialties certification has emerged internationally as a mechanism to support advanced pharmacy practice and professional differentiation. However, little is known about how BPS-certified pharmacists perceive its value within health care systems with specialist training pathways, such as in Spain. This study aimed to explore the perceived value, professional impact, and implementation barriers of BPS certification among hospital pharmacists in Spain.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A qualitative descriptive study used semi-structured interviews with BPS-certified hospital pharmacists practicing in Spain. Participants were purposively recruited to ensure diversity in certification specialty, geographical region, and profile. Interviews were conducted between April and June 2026, audio-recorded, transcribed, and analyzed using qualitative content analysis. Reporting followed Consolidated Criteria for Reporting Qualitative Research.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Eleven hospital pharmacists representing multiple BPS specialties participated. Participants perceived BPS certification as strengthening clinical competence, improving confidence in pharmacotherapeutic decision-making, and supporting advanced clinical practice. Certification was perceived to enhance professional credibility within interprofessional clinical teams and among pharmacist colleagues. However, participants described limited institutional recognition, with little impact on salary, career progression, employment systems, or protected professional development time. Major barriers included time investment, economic costs, recertification requirements, and partial mismatch between the United States–oriented examination framework and the Spanish health care context. Participants viewed BPS certification as a complementary credential to the national hospital pharmacy residency system rather than a substitute for specialist training. Most anticipated demand for credentialing would continue to increase as hospital pharmacy practice becomes specialized and clinically complex.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;BPS certification is perceived as a valuable mechanism supporting advanced clinical competence, professional differentiation, and integration into interprofessional practice. Nevertheless, broader implementation remains limited by insufficient institutional recognition and structural support. Greater alignment between international credentialing systems and national professional dev","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 10","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70286","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148909980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of a Pharmacy-Led Psychotropic Stewardship Pilot Program at an Academic Medical Center","authors":"Olivia King,&nbsp;Jessica Cather,&nbsp;Paula Politis,&nbsp;Todd Ivan","doi":"10.1002/jac5.70290","DOIUrl":"10.1002/jac5.70290","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Psychotropic stewardship programs (PSPs) have been proposed to optimize psychiatric medication use and improve medication safety; however, data describing their implementation and impact in general medical inpatient settings remain limited. This quality improvement project evaluated a pharmacist-led PSP pilot at an academic medical center.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Adult inpatients were identified using predefined criteria including use of high-risk psychotropic agents (carbamazepine, clozapine, lithium, lamotrigine, valproic acid [VPA]), scheduled benzodiazepines in patients 65 years and older, and psychotropic polypharmacy (≥ 3 antidepressants or ≥ 2 antipsychotics). Pharmacists and prescribers could also identify patients for review. Exclusion criteria included admission to inpatient behavioral health units, active psychiatry consultation, admission to the acute palliative care/hospice unit, and emergency department status. Over 1 month, a pharmacist conducted chart reviews and collaborated with a psychiatrist to provide recommendations to primary teams. Interventions and outcomes were tracked and summarized using descriptive statistics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>During the pilot period, 626 patients were flagged for review; 473 met inclusion criteria and 190 underwent full evaluation. A total of 176 psychotropic stewardship interventions were recommended, of which 162 were accepted (92%). Patients were most identified by direct prescriber- or pharmacist-initiated review (51.1%) and high-risk psychotropic use (30.1%). Medication reconciliation (29.0%) accounted for the largest proportion of interventions made, followed by dose optimization (26.1%) and medication discontinuation (13.6%). Selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) were the most frequently involved medication classes (23.9%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>A pharmacist-led PSP was feasible in a general medical inpatient setting and resulted in a high rate of accepted interventions. These findings support the role of pharmacists in improving psychotropic medication safety and highlight opportunities for targeted, system-level interventions. Future work should evaluate clinical outcomes and long-term sustainability of PSPs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 9","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}